nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—HTR2A—conduct disorder	0.863	1	CbGaD
Promethazine—CALM1—autonomic nervous system—conduct disorder	0.00426	0.319	CbGeAlD
Promethazine—HTR2A—autonomic nervous system—conduct disorder	0.00259	0.194	CbGeAlD
Promethazine—CHRM4—brain—conduct disorder	0.000967	0.0724	CbGeAlD
Promethazine—CHRM5—brain—conduct disorder	0.000756	0.0566	CbGeAlD
Promethazine—Propiomazine—DRD4—conduct disorder	0.000688	0.0652	CrCbGaD
Promethazine—Cyamemazine—HTR2A—conduct disorder	0.000617	0.0585	CrCbGaD
Promethazine—Methotrimeprazine—DRD4—conduct disorder	0.000588	0.0558	CrCbGaD
Promethazine—Cyclobenzaprine—HTR2A—conduct disorder	0.000574	0.0544	CrCbGaD
Promethazine—CALM3—brain—conduct disorder	0.000527	0.0394	CbGeAlD
Promethazine—CHRM2—brain—conduct disorder	0.000519	0.0388	CbGeAlD
Promethazine—Promazine—DRD4—conduct disorder	0.00051	0.0483	CrCbGaD
Promethazine—CHRM1—brain—conduct disorder	0.000472	0.0353	CbGeAlD
Promethazine—Chlorpromazine—DRD4—conduct disorder	0.000448	0.0425	CrCbGaD
Promethazine—CHRM3—brain—conduct disorder	0.000423	0.0316	CbGeAlD
Promethazine—CALM2—brain—conduct disorder	0.000414	0.031	CbGeAlD
Promethazine—CALM1—brain—conduct disorder	0.000412	0.0308	CbGeAlD
Promethazine—Acepromazine—HTR2A—conduct disorder	0.000397	0.0376	CrCbGaD
Promethazine—Clomipramine—SLC6A4—conduct disorder	0.000392	0.0372	CrCbGaD
Promethazine—ADRA1A—brain—conduct disorder	0.000388	0.029	CbGeAlD
Promethazine—Thioproperazine—HTR2A—conduct disorder	0.000388	0.0368	CrCbGaD
Promethazine—Pipotiazine—HTR2A—conduct disorder	0.000381	0.0362	CrCbGaD
Promethazine—DRD2—brain—conduct disorder	0.00038	0.0285	CbGeAlD
Promethazine—Mesoridazine—HTR2A—conduct disorder	0.000376	0.0357	CrCbGaD
Promethazine—Trimipramine—SLC6A4—conduct disorder	0.000361	0.0342	CrCbGaD
Promethazine—Doxepin—SLC6A4—conduct disorder	0.000344	0.0326	CrCbGaD
Promethazine—Propiomazine—HTR2A—conduct disorder	0.000317	0.0301	CrCbGaD
Promethazine—Desipramine—SLC6A4—conduct disorder	0.000316	0.0299	CrCbGaD
Promethazine—CYP2B6—brain—conduct disorder	0.000308	0.023	CbGeAlD
Promethazine—Clomipramine—HTR2A—conduct disorder	0.000301	0.0286	CrCbGaD
Promethazine—HRH1—brain—conduct disorder	0.0003	0.0225	CbGeAlD
Promethazine—Chlorprothixene—HTR2A—conduct disorder	0.0003	0.0285	CrCbGaD
Promethazine—Thioridazine—HTR2A—conduct disorder	0.000284	0.0269	CrCbGaD
Promethazine—Trimipramine—HTR2A—conduct disorder	0.000277	0.0263	CrCbGaD
Promethazine—Methotrimeprazine—HTR2A—conduct disorder	0.000271	0.0257	CrCbGaD
Promethazine—Imipramine—SLC6A4—conduct disorder	0.000268	0.0254	CrCbGaD
Promethazine—Amitriptyline—SLC6A4—conduct disorder	0.000266	0.0252	CrCbGaD
Promethazine—Doxepin—HTR2A—conduct disorder	0.000264	0.0251	CrCbGaD
Promethazine—Trifluoperazine—HTR2A—conduct disorder	0.000264	0.025	CrCbGaD
Promethazine—Perphenazine—HTR2A—conduct disorder	0.000261	0.0247	CrCbGaD
Promethazine—HTR2A—brain—conduct disorder	0.000251	0.0188	CbGeAlD
Promethazine—Desipramine—HTR2A—conduct disorder	0.000243	0.023	CrCbGaD
Promethazine—Promazine—HTR2A—conduct disorder	0.000235	0.0223	CrCbGaD
Promethazine—CYP2D6—brain—conduct disorder	0.000229	0.0171	CbGeAlD
Promethazine—Chlorpromazine—HTR2A—conduct disorder	0.000207	0.0196	CrCbGaD
Promethazine—Imipramine—HTR2A—conduct disorder	0.000206	0.0195	CrCbGaD
Promethazine—Amitriptyline—HTR2A—conduct disorder	0.000204	0.0194	CrCbGaD
Promethazine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000193	0.00171	CbGpPWpGaD
Promethazine—CALM3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000192	0.0017	CbGpPWpGaD
Promethazine—CALM3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000191	0.00169	CbGpPWpGaD
Promethazine—CALM2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000186	0.00165	CbGpPWpGaD
Promethazine—CALM1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000186	0.00165	CbGpPWpGaD
Promethazine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000185	0.00164	CbGpPWpGaD
Promethazine—CALM2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000184	0.00163	CbGpPWpGaD
Promethazine—CALM1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000184	0.00163	CbGpPWpGaD
Promethazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000176	0.00156	CbGpPWpGaD
Promethazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000176	0.00156	CbGpPWpGaD
Promethazine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000175	0.00155	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—WASF1—conduct disorder	0.000174	0.00154	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—POLR3A—conduct disorder	0.000173	0.00154	CbGpPWpGaD
Promethazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000173	0.00153	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—POLR3A—conduct disorder	0.000168	0.00149	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—POLR3A—conduct disorder	0.000168	0.00149	CbGpPWpGaD
Promethazine—ABCB1—brain—conduct disorder	0.000164	0.0123	CbGeAlD
Promethazine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000157	0.00139	CbGpPWpGaD
Promethazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000155	0.00137	CbGpPWpGaD
Promethazine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000155	0.00137	CbGpPWpGaD
Promethazine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000155	0.00137	CbGpPWpGaD
Promethazine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000154	0.00137	CbGpPWpGaD
Promethazine—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.000154	0.00136	CbGpPWpGaD
Promethazine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000154	0.00136	CbGpPWpGaD
Promethazine—CYP2C9—Biological oxidations—COMT—conduct disorder	0.000153	0.00136	CbGpPWpGaD
Promethazine—CHRM1—GPCR downstream signaling—CGA—conduct disorder	0.000153	0.00136	CbGpPWpGaD
Promethazine—CHRM3—GPCR downstream signaling—CGA—conduct disorder	0.000153	0.00135	CbGpPWpGaD
Promethazine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000153	0.00135	CbGpPWpGaD
Promethazine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000153	0.00135	CbGpPWpGaD
Promethazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000152	0.00135	CbGpPWpGaD
Promethazine—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.000152	0.00135	CbGpPWpGaD
Promethazine—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.000152	0.00135	CbGpPWpGaD
Promethazine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000152	0.00135	CbGpPWpGaD
Promethazine—CHRM1—GPCR ligand binding—DRD4—conduct disorder	0.000152	0.00135	CbGpPWpGaD
Promethazine—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000151	0.00134	CbGpPWpGaD
Promethazine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000151	0.00134	CbGpPWpGaD
Promethazine—CHRM3—GPCR ligand binding—DRD4—conduct disorder	0.000151	0.00134	CbGpPWpGaD
Promethazine—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.000151	0.00134	CbGpPWpGaD
Promethazine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.000151	0.00134	CbGpPWpGaD
Promethazine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.000151	0.00134	CbGpPWpGaD
Promethazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00015	0.00133	CbGpPWpGaD
Promethazine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.00015	0.00133	CbGpPWpGaD
Promethazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000149	0.00132	CbGpPWpGaD
Promethazine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.000149	0.00132	CbGpPWpGaD
Promethazine—HRH4—GPCR downstream signaling—HTR2A—conduct disorder	0.000148	0.00131	CbGpPWpGaD
Promethazine—CALM3—Neuronal System—COMT—conduct disorder	0.000147	0.0013	CbGpPWpGaD
Promethazine—CHRM4—GPCR ligand binding—HTR2A—conduct disorder	0.000147	0.0013	CbGpPWpGaD
Promethazine—CALM3—Neuronal System—MAOA—conduct disorder	0.000146	0.00129	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—WASF1—conduct disorder	0.000146	0.00129	CbGpPWpGaD
Promethazine—CALM2—Neuronal System—COMT—conduct disorder	0.000142	0.00126	CbGpPWpGaD
Promethazine—CALM1—Neuronal System—COMT—conduct disorder	0.000142	0.00126	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000142	0.00126	CbGpPWpGaD
Promethazine—CALM2—Neuronal System—MAOA—conduct disorder	0.000141	0.00125	CbGpPWpGaD
Promethazine—CALM1—Neuronal System—MAOA—conduct disorder	0.000141	0.00125	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—WASF1—conduct disorder	0.000141	0.00125	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—WASF1—conduct disorder	0.000141	0.00125	CbGpPWpGaD
Promethazine—CHRM5—GPCR ligand binding—HTR2A—conduct disorder	0.000141	0.00125	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.00014	0.00124	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—CGA—conduct disorder	0.00014	0.00124	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—CGA—conduct disorder	0.000139	0.00123	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—CGA—conduct disorder	0.000139	0.00123	CbGpPWpGaD
Promethazine—CALM3—Immune System—MB21D1—conduct disorder	0.000138	0.00122	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.000137	0.00122	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.000137	0.00121	CbGpPWpGaD
Promethazine—HRH4—Signaling by GPCR—HTR2A—conduct disorder	0.000134	0.00119	CbGpPWpGaD
Promethazine—CALM2—Immune System—MB21D1—conduct disorder	0.000133	0.00118	CbGpPWpGaD
Promethazine—CALM1—Immune System—MB21D1—conduct disorder	0.000133	0.00118	CbGpPWpGaD
Promethazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000133	0.00118	CbGpPWpGaD
Promethazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00013	0.00116	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00013	0.00116	CbGpPWpGaD
Promethazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00013	0.00115	CbGpPWpGaD
Promethazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00013	0.00115	CbGpPWpGaD
Promethazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000128	0.00114	CbGpPWpGaD
Promethazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000128	0.00113	CbGpPWpGaD
Promethazine—CHRM4—GPCR downstream signaling—DRD4—conduct disorder	0.000127	0.00113	CbGpPWpGaD
Promethazine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000124	0.0011	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—CGA—conduct disorder	0.000122	0.00108	CbGpPWpGaD
Promethazine—CHRM5—GPCR downstream signaling—DRD4—conduct disorder	0.000122	0.00108	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—DRD4—conduct disorder	0.000122	0.00108	CbGpPWpGaD
Promethazine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000121	0.00107	CbGpPWpGaD
Promethazine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000119	0.00105	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—CGA—conduct disorder	0.000117	0.00103	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—CGA—conduct disorder	0.000116	0.00103	CbGpPWpGaD
Promethazine—CHRM4—Signaling by GPCR—DRD4—conduct disorder	0.000116	0.00102	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—CGA—conduct disorder	0.000112	0.000996	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—CGA—conduct disorder	0.000112	0.000996	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—DRD4—conduct disorder	0.000111	0.000981	CbGpPWpGaD
Promethazine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.000101	0.000897	CbGpPWpGaD
Promethazine—CALM3—Immune System—POLR3A—conduct disorder	0.000101	0.000895	CbGpPWpGaD
Promethazine—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.0001	0.00089	CbGpPWpGaD
Promethazine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	9.94e-05	0.000881	CbGpPWpGaD
Promethazine—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	9.91e-05	0.000878	CbGpPWpGaD
Promethazine—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	9.87e-05	0.000875	CbGpPWpGaD
Promethazine—CHRM1—Circadian rythm related genes—EP300—conduct disorder	9.82e-05	0.000871	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—CGA—conduct disorder	9.8e-05	0.000868	CbGpPWpGaD
Promethazine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	9.78e-05	0.000867	CbGpPWpGaD
Promethazine—CALM2—Immune System—POLR3A—conduct disorder	9.77e-05	0.000866	CbGpPWpGaD
Promethazine—CALM1—Immune System—POLR3A—conduct disorder	9.77e-05	0.000866	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—WASF1—conduct disorder	9.77e-05	0.000866	CbGpPWpGaD
Promethazine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	9.75e-05	0.000864	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—WASF1—conduct disorder	9.35e-05	0.000829	CbGpPWpGaD
Promethazine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	8.77e-05	0.000777	CbGpPWpGaD
Promethazine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	8.63e-05	0.000765	CbGpPWpGaD
Promethazine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	8.61e-05	0.000763	CbGpPWpGaD
Promethazine—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	8.58e-05	0.00076	CbGpPWpGaD
Promethazine—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	8.55e-05	0.000758	CbGpPWpGaD
Promethazine—CALM3—Immune System—WASF1—conduct disorder	8.5e-05	0.000754	CbGpPWpGaD
Promethazine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	8.47e-05	0.000751	CbGpPWpGaD
Promethazine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	8.45e-05	0.000749	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—CGA—conduct disorder	8.43e-05	0.000747	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CGA—conduct disorder	8.4e-05	0.000744	CbGpPWpGaD
Promethazine—CHRM4—GPCR downstream signaling—HTR2A—conduct disorder	8.3e-05	0.000736	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CGA—conduct disorder	8.26e-05	0.000732	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CGA—conduct disorder	8.24e-05	0.000731	CbGpPWpGaD
Promethazine—CALM2—Immune System—WASF1—conduct disorder	8.22e-05	0.000729	CbGpPWpGaD
Promethazine—CALM1—Immune System—WASF1—conduct disorder	8.22e-05	0.000729	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CGA—conduct disorder	8.22e-05	0.000728	CbGpPWpGaD
Promethazine—CALM3—Metabolism—CGA—conduct disorder	8.2e-05	0.000727	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CGA—conduct disorder	8.19e-05	0.000726	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CGA—conduct disorder	8.11e-05	0.000719	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CGA—conduct disorder	8.09e-05	0.000717	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—DRD4—conduct disorder	7.96e-05	0.000706	CbGpPWpGaD
Promethazine—CHRM5—GPCR downstream signaling—HTR2A—conduct disorder	7.95e-05	0.000705	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—HTR2A—conduct disorder	7.94e-05	0.000704	CbGpPWpGaD
Promethazine—CALM2—Metabolism—CGA—conduct disorder	7.93e-05	0.000703	CbGpPWpGaD
Promethazine—CALM1—Metabolism—CGA—conduct disorder	7.93e-05	0.000703	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	7.83e-05	0.000694	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—DRD4—conduct disorder	7.82e-05	0.000693	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—DRD4—conduct disorder	7.79e-05	0.000691	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—DRD4—conduct disorder	7.77e-05	0.000688	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	7.69e-05	0.000682	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	7.67e-05	0.00068	CbGpPWpGaD
Promethazine—CHRM4—Signaling by GPCR—HTR2A—conduct disorder	7.54e-05	0.000668	CbGpPWpGaD
Promethazine—CALM3—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	7.44e-05	0.000659	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—HTR2A—conduct disorder	7.22e-05	0.00064	CbGpPWpGaD
Promethazine—CALM1—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	7.19e-05	0.000638	CbGpPWpGaD
Promethazine—CALM2—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	7.19e-05	0.000638	CbGpPWpGaD
Promethazine—CALM3—Signaling by WNT in cancer—EP300—conduct disorder	6.91e-05	0.000612	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CGA—conduct disorder	6.86e-05	0.000608	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—DRD4—conduct disorder	6.83e-05	0.000605	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—WASF1—conduct disorder	6.73e-05	0.000597	CbGpPWpGaD
Promethazine—CALM1—Signaling by WNT in cancer—EP300—conduct disorder	6.68e-05	0.000592	CbGpPWpGaD
Promethazine—CALM2—Signaling by WNT in cancer—EP300—conduct disorder	6.68e-05	0.000592	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CGA—conduct disorder	6.63e-05	0.000588	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CGA—conduct disorder	6.63e-05	0.000588	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—WASF1—conduct disorder	6.62e-05	0.000587	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—WASF1—conduct disorder	6.61e-05	0.000586	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—WASF1—conduct disorder	6.59e-05	0.000584	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—WASF1—conduct disorder	6.57e-05	0.000582	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—DRD4—conduct disorder	6.54e-05	0.000579	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—DRD4—conduct disorder	6.5e-05	0.000576	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—WASF1—conduct disorder	6.5e-05	0.000576	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	6.48e-05	0.000575	CbGpPWpGaD
Promethazine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	6.47e-05	0.000574	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—DRD4—conduct disorder	6.29e-05	0.000558	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—DRD4—conduct disorder	6.29e-05	0.000558	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—CGA—conduct disorder	6.22e-05	0.000551	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—CGA—conduct disorder	5.86e-05	0.000519	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—CGA—conduct disorder	5.81e-05	0.000515	CbGpPWpGaD
Promethazine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	5.72e-05	0.000507	CbGpPWpGaD
Promethazine—CALM3—Signaling by Wnt—EP300—conduct disorder	5.69e-05	0.000505	CbGpPWpGaD
Promethazine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	5.62e-05	0.000498	CbGpPWpGaD
Promethazine—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	5.6e-05	0.000496	CbGpPWpGaD
Promethazine—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	5.58e-05	0.000495	CbGpPWpGaD
Promethazine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	5.53e-05	0.00049	CbGpPWpGaD
Promethazine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	5.51e-05	0.000488	CbGpPWpGaD
Promethazine—CALM1—Signaling by Wnt—EP300—conduct disorder	5.51e-05	0.000488	CbGpPWpGaD
Promethazine—CALM2—Signaling by Wnt—EP300—conduct disorder	5.51e-05	0.000488	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—WASF1—conduct disorder	5.5e-05	0.000487	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—WASF1—conduct disorder	5.32e-05	0.000471	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—WASF1—conduct disorder	5.32e-05	0.000471	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	5.19e-05	0.00046	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	5.1e-05	0.000452	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	5.08e-05	0.000451	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	5.07e-05	0.000449	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	5.02e-05	0.000445	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	5e-05	0.000444	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—DRD4—conduct disorder	4.7e-05	0.000417	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—DRD4—conduct disorder	4.63e-05	0.00041	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—DRD4—conduct disorder	4.62e-05	0.000409	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—DRD4—conduct disorder	4.6e-05	0.000408	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—DRD4—conduct disorder	4.59e-05	0.000407	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—DRD4—conduct disorder	4.54e-05	0.000403	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	4.53e-05	0.000402	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—HTR2A—conduct disorder	4.45e-05	0.000395	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—COMT—conduct disorder	4.42e-05	0.000392	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—MAOA—conduct disorder	4.39e-05	0.000389	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—HTR2A—conduct disorder	4.26e-05	0.000378	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—HTR2A—conduct disorder	4.24e-05	0.000376	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—EP300—conduct disorder	4.21e-05	0.000373	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—HTR2A—conduct disorder	4.1e-05	0.000364	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—HTR2A—conduct disorder	4.1e-05	0.000364	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—EP300—conduct disorder	3.92e-05	0.000347	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—DRD4—conduct disorder	3.84e-05	0.00034	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—COMT—conduct disorder	3.8e-05	0.000337	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—EP300—conduct disorder	3.79e-05	0.000336	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—EP300—conduct disorder	3.79e-05	0.000336	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—MAOA—conduct disorder	3.78e-05	0.000335	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—DRD4—conduct disorder	3.72e-05	0.000329	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—DRD4—conduct disorder	3.72e-05	0.000329	CbGpPWpGaD
Promethazine—CALM3—Metabolism—COMT—conduct disorder	3.7e-05	0.000328	CbGpPWpGaD
Promethazine—CALM3—Metabolism—MAOA—conduct disorder	3.68e-05	0.000326	CbGpPWpGaD
Promethazine—CALM2—Metabolism—COMT—conduct disorder	3.58e-05	0.000317	CbGpPWpGaD
Promethazine—CALM1—Metabolism—COMT—conduct disorder	3.58e-05	0.000317	CbGpPWpGaD
Promethazine—CALM2—Metabolism—MAOA—conduct disorder	3.56e-05	0.000315	CbGpPWpGaD
Promethazine—CALM1—Metabolism—MAOA—conduct disorder	3.56e-05	0.000315	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—EP300—conduct disorder	3.53e-05	0.000313	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—EP300—conduct disorder	3.41e-05	0.000302	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—EP300—conduct disorder	3.41e-05	0.000302	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HTR2A—conduct disorder	3.07e-05	0.000272	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HTR2A—conduct disorder	3.01e-05	0.000267	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HTR2A—conduct disorder	3e-05	0.000266	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HTR2A—conduct disorder	2.99e-05	0.000265	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	2.96e-05	0.000263	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	2.96e-05	0.000262	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—COMT—conduct disorder	2.81e-05	0.000249	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—MAOA—conduct disorder	2.79e-05	0.000247	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—COMT—conduct disorder	2.64e-05	0.000234	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—MAOA—conduct disorder	2.63e-05	0.000233	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—COMT—conduct disorder	2.62e-05	0.000232	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—MAOA—conduct disorder	2.6e-05	0.000231	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.52e-05	0.000224	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HTR2A—conduct disorder	2.51e-05	0.000222	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HTR2A—conduct disorder	2.42e-05	0.000215	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HTR2A—conduct disorder	2.42e-05	0.000215	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—EP300—conduct disorder	2.36e-05	0.000209	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—EP300—conduct disorder	2.26e-05	0.0002	CbGpPWpGaD
Promethazine—CALM3—Immune System—EP300—conduct disorder	2.05e-05	0.000182	CbGpPWpGaD
Promethazine—CALM2—Immune System—EP300—conduct disorder	1.99e-05	0.000176	CbGpPWpGaD
Promethazine—CALM1—Immune System—EP300—conduct disorder	1.99e-05	0.000176	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—EP300—conduct disorder	1.9e-05	0.000168	CbGpPWpGaD
Promethazine—CALM3—Disease—EP300—conduct disorder	1.9e-05	0.000168	CbGpPWpGaD
Promethazine—CALM2—Disease—EP300—conduct disorder	1.83e-05	0.000163	CbGpPWpGaD
Promethazine—CALM1—Disease—EP300—conduct disorder	1.83e-05	0.000163	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—EP300—conduct disorder	1.63e-05	0.000145	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—EP300—conduct disorder	1.63e-05	0.000144	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EP300—conduct disorder	1.6e-05	0.000142	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EP300—conduct disorder	1.6e-05	0.000141	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EP300—conduct disorder	1.59e-05	0.000141	CbGpPWpGaD
Promethazine—CALM3—Metabolism—EP300—conduct disorder	1.59e-05	0.000141	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EP300—conduct disorder	1.59e-05	0.000141	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EP300—conduct disorder	1.57e-05	0.000139	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EP300—conduct disorder	1.57e-05	0.000139	CbGpPWpGaD
Promethazine—CALM1—Metabolism—EP300—conduct disorder	1.54e-05	0.000136	CbGpPWpGaD
Promethazine—CALM2—Metabolism—EP300—conduct disorder	1.54e-05	0.000136	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EP300—conduct disorder	1.33e-05	0.000118	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EP300—conduct disorder	1.28e-05	0.000114	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EP300—conduct disorder	1.28e-05	0.000114	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—EP300—conduct disorder	1.2e-05	0.000107	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—EP300—conduct disorder	1.13e-05	0.000101	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—EP300—conduct disorder	1.12e-05	9.96e-05	CbGpPWpGaD
